—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Caris Life Sciences, Inc. Common Stock (CAI) — Technical state

As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 60 out of 100 (momentum 94 · quality 61 · valuation 24), as of 2026-11-01.
  • Signal: Uptrend stack intact — Trades +17.7% vs the 50-day and +59.1% vs the 200-day average, 5.9% below the 52-week high and +141.9% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes. (as of 2026-10-30)
  • Trend: Caris Life Sciences, Inc. Common Stock trades 17.7% above its 50-day and 59.1% above its 200-day moving average. (as of 2026-10-30)

Caris Life Sciences profiles tumours at the molecular level, sequencing DNA, RNA and whole genomes to guide cancer treatment choices. Its platforms cover tissue and blood based tests, including whole exome and whole genome sequencing, early detection and residual disease monitoring tools.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the CAI overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +17.7% vs the 50-day and +59.1% vs the 200-day average, 5.9% below the 52-week high and +141.9% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes.

Ranked #5 on today’s Directional Flow — Rising fastest list (scan of 2026-11-02).

The moving-average stack

Continue: the CAI chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-30

Quick answers

What is the current Closelooknet signal on CAI?

Uptrend stack intact — Trades +17.7% vs the 50-day and +59.1% vs the 200-day average, 5.9% below the 52-week high and +141.9% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CAI above its 50-day and 200-day moving averages?

As of 2026-10-30, Caris Life Sciences, Inc. Common Stock trades +17.7% above its 50-day and +59.1% above its 200-day average, with the 20-day +10.1% away.

How far is CAI from its 52-week high?

5.9% below the 52-week high and 141.9% above the 52-week low, as of 2026-10-30.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.